Preparation method of hemoglobin control freeze-dried product

文档序号：795806 发布日期：2021-04-13 浏览：39次中文

阅读说明：本技术 一种血红蛋白质控品冻干品的制备方法 (Preparation method of hemoglobin control freeze-dried product ) 是由莫海飞于 2020-12-22 设计创作，主要内容包括：本发明公开了一种血红蛋白质控品冻干品的制备方法。该方法,包括如下步骤：(1)向pH值为4.0～8.2的缓冲剂中依次加入多元醇类保护剂、氨基酸保护剂和糖类保护剂,得到血红蛋白质控品稀释液；(2)向步骤(1)得到的血红蛋白质控品稀释液中加入血红蛋白质控品样品,得到血红蛋白质控品溶液,血红蛋白质控品样品与缓冲剂的体积比为0.0005:1；(3)将步骤(2)得到的血红蛋白质控品溶液进行冷冻干燥得到血红蛋白质控品冻干品,冷冻干燥的条件为：温度为-60℃～-30℃,压力为1～30Pa,时间为12～36小时。本发明提出的血红蛋白质控品冻干品的制备方法,操作简单方便；得到的血红蛋白质控品冻干粉质控品瓶间差小于15％,质控品精密性CV小于15％,且血红蛋白质控品可稳定冷藏6个月。(The invention discloses a preparation method of a freeze-dried hemoglobin control product. The method comprises the following steps: (1) sequentially adding a polyol protective agent, an amino acid protective agent and a saccharide protective agent into a buffering agent with the pH value of 4.0-8.2 to obtain a hemoglobin quality control product diluent; (2) adding a hemoglobin quality control sample into the hemoglobin quality control diluent obtained in the step (1) to obtain a hemoglobin quality control solution, wherein the volume ratio of the hemoglobin quality control sample to the buffer is 0.0005: 1; (3) and (3) freeze-drying the hemoglobin control solution obtained in the step (2) to obtain a freeze-dried hemoglobin control product, wherein the freeze-drying conditions are as follows: the temperature is-60 ℃ to-30 ℃, the pressure is 1 Pa to 30Pa, and the time is 12 hours to 36 hours. The preparation method of the hemoglobin control freeze-dried product provided by the invention is simple and convenient to operate; the difference between the quality control product bottles of the obtained hemoglobin control product freeze-dried powder is less than 15 percent, the precision CV of the quality control product is less than 15 percent, and the hemoglobin control product can be stably refrigerated for 6 months.)

1. A preparation method of a freeze-dried hemoglobin control product is characterized by comprising the following steps:

(1) sequentially adding a polyol protective agent, an amino acid protective agent and a saccharide protective agent into a buffering agent with the pH value of 4.0-8.2 to obtain a hemoglobin quality control product diluent, wherein the polyol protective agent accounts for 1-10% of the hemoglobin quality control product diluent in mass percent, the amino acid protective agent accounts for 1-10% of the hemoglobin quality control product diluent in mass percent, and the saccharide protective agent accounts for 1-10% of the hemoglobin quality control product diluent in mass percent;

(2) adding a hemoglobin quality control sample into the hemoglobin quality control diluent obtained in the step (1) to obtain a hemoglobin quality control solution, wherein the volume ratio of the hemoglobin quality control sample to the buffer is 0.0005: 1;

(3) and (3) freeze-drying the hemoglobin control solution obtained in the step (2) to obtain a freeze-dried hemoglobin control product, wherein the freeze-drying conditions are as follows: the temperature is-60 ℃ to-30 ℃, the pressure is 1 Pa to 30Pa, and the time is 12 hours to 36 hours.

2. The method for preparing the freeze-dried hemoglobin control product according to claim 1, wherein the pH value of the buffer in step (1) is 7.0-8.0, and the buffer is selected from one or more of boric acid, phosphoric acid, trihydroxymethylaminomethane, borate and phosphate.

3. The method for preparing the freeze-dried hemoglobin control product according to claim 1 or 2, wherein the buffer in step (1) has a molar concentration of 10 to 200 mmol/L.

4. The method for preparing the freeze-dried hemoglobin control product of claim 1, wherein the polyol protectant in step (1) is at least one selected from the group consisting of glycerol, xylitol, mannitol, sorbitol and polyethylene glycol.

5. The method for preparing the freeze-dried hemoglobin control product of claim 1, wherein the amino acid protectant in step (1) is at least one selected from the group consisting of glycine, cysteine, N-acetylcysteine and glutathione.

6. The method for preparing a lyophilized hemoglobin control product of claim 1, wherein the sugar-based protective agent of step (1) is one or more selected from sucrose, glucose, trehalose, lactose and maltose.

7. The method for preparing a lyophilized hemoglobin control product as claimed in claim 1, wherein the freeze-drying conditions in step (3) are as follows: pre-freezing for 3-5 hours at the temperature of-60 ℃ to-30 ℃, then forming, freezing and vacuumizing for 8-15 hours, and freeze-drying pressure is 1-30 pa.

8. The method for preparing the freeze-dried hemoglobin control product of claim 1, wherein the difference between the vials of the freeze-dried hemoglobin control product is less than 15% and the precision CV of the quality control product is less than 15%.

Technical Field

The invention relates to the technical field of medical inspection, in particular to a preparation method of a freeze-dried hemoglobin control product.

Background

In the state of solution, hemoglobin is very unstable, and can be oxidized and autooxidized under natural conditions, such as dissolved oxygen, illumination, heating and the like, so that the structure of hemoglobin is changed, ferrous hemoglobin is oxidized into methemoglobin, and then oxygen carrying capacity is lost. Research shows that the hemoglobin subjected to vacuum freeze drying is more stable, is not easy to oxidize and has a more stable structure, so that the purpose of long-term storage of the hemoglobin can be achieved by a vacuum freeze drying method. The hemoglobin quality control product is used for quality control, has higher requirements on the quality control product, and has the characteristics of good precision, poor bottle-to-bottle property, stability and the like as the quality control product. At present, in the diagnostic reagent industry, it is important to ensure the quality of diagnostic reagents, and thus quality control products become an indispensable part, and thus, the demand for quality control products in the market is increasing. The hemoglobin quality control product is unstable, and meanwhile, the precision and the difference between bottles are considered, so that the technical difficulty of preparing the hemoglobin quality control product is greatly increased.

Disclosure of Invention

The invention provides a preparation method of a freeze-dried hemoglobin control product, which aims to provide the freeze-dried hemoglobin control product with the precision of less than 15 percent and the difference between bottles of less than 15 percent, and can be stored for more than 6 months at the temperature of 20 ℃ below zero, thereby providing a stable and good quality control product for the detection of a hemoglobin diagnostic reagent.

The invention aims to provide a preparation method of a freeze-dried hemoglobin control product, which comprises the following steps:

The invention adjusts the formula of the hemoglobin quality control product by adding a buffering agent with a proper pH value, adds a polyol protective agent, an amino acid protective agent and a saccharide protective agent, and obtains the freeze-dried product of the hemoglobin quality control product after vacuum freeze drying. The difference between the freeze-dried hemoglobin control product and quality control product bottles is less than 15 percent; the precision CV of the quality control product is less than 15 percent; and the hemoglobin control product can be stably refrigerated for 6 months. The hemoglobin quality control sample can be a high-value quality control sample or a low-value quality control sample.

Preferably, the pH value of the buffering agent in the step (1) is 7.0-8.0, and the buffering agent is selected from more than one of boric acid, phosphoric acid, trihydroxy methylamino methane, borate and phosphate.

In the present invention, the buffer agent is preferably a neutral pH range because the pH of the hemoglobin control product can be stably maintained in a certain range and the stability of hemoglobin can be impaired under extreme acid or alkali conditions. Temperature is an important factor affecting pH and studies have shown that the pH of a dilution containing sodium salt is 7.0, at-40 c, the pH is only 5.4 and hemoglobin is destroyed, whereas the pH of a dilution is relatively stable with potassium salt at-40 c, the buffer preferably being potassium phosphate.

Preferably, the molar concentration of the buffer in the step (1) is 10-200 mmol/L.

Preferably, the polyol protective agent in step (1) is one or more selected from glycerol, xylitol, mannitol, sorbitol and polyethylene glycol. During the low-temperature pre-freezing, freeze-drying and preservation of biological products, polyols including glycerol (glycerin), sorbitol and mannitol are used more frequently, and since the functional groups of the polyols are hydroxyl groups, they are used as cryoprotectants, freeze-drying protectants and plasticizers.

Preferably, the amino acid protecting agent in the step (1) is selected from more than one of glycine, cysteine, N-acetylcysteine and glutathione. The addition of amino acid is beneficial to the maintenance of the activity of hemoglobin, and because the amino acid ions have both acid and alkali, the pH change of the solution can be inhibited in the processes of low-temperature preservation and freeze drying of biological products, thereby achieving the aim of protecting active components.

Preferably, the sugar protective agent in step (1) is one or more selected from sucrose, glucose, trehalose, lactose and maltose. Oligosaccharides, especially disaccharides, are often used as protectants during the freeze-drying of biologics, since disaccharides can function as cryoprotectants during freezing; but also can play the role of a dehydration protective agent in the drying and dehydration process.

Preferably, the conditions of the freeze-drying in the step (3) are as follows: pre-freezing for 3-5 hours at the temperature of-60 ℃ to-30 ℃, then forming, freezing and vacuumizing for 8-15 hours, and freeze-drying pressure is 1-30 pa.

Preferably, the difference between the hemoglobin control freeze-dried product bottles is less than 15%, and the precision CV of the quality control product is less than 15%. The quality control product provided by the invention comprises two concentrations of a high-value quality control product and a low-value quality control product, and provides an immunological determination method for the hemoglobin quality control product by using the hemoglobin diagnostic reagent. Examples of the immunological measurement method include a colloidal gold agglutination method, an immunochromatography method, an ELISA method, an immunofluorescence method, and the like.

Compared with the prior art, the invention has the beneficial effects that:

1. the preparation method of the hemoglobin control freeze-dried product provided by the invention is simple and convenient to operate; the difference between the quality control product bottles of the obtained hemoglobin control product freeze-dried powder is less than 15 percent, the precision CV of the quality control product is less than 15 percent, and the hemoglobin control product can be stably refrigerated for 6 months.

2. The present invention can stably maintain hemoglobin without degradation and with good precision by allowing a buffer and a hemoglobin protective agent to coexist in a sample containing a lyophilized product of a hemoglobin quality control product, and can be suitably used for quality control of a hemoglobin immunodiagnostic reagent.

Detailed Description

The following examples are further illustrative of the present invention and are not intended to be limiting thereof. The equipment and reagents used in the present invention are, unless otherwise specified, conventional commercial products in the art. The hemoglobin control product provided by the invention is purchased from Sigma, lot: SLCC 1154.

Example 1

Potassium borate, potassium phosphate and tris (hydroxymethyl) aminomethane were prepared at a molar concentration of 100mM, pH7.4, respectively. 10mL of each of potassium borate, potassium phosphate and tris (hydroxymethyl) aminomethane are respectively numbered as # 1, # 2 and # 3 in sequence, wherein 10mL of purified water is used as a buffer agent as a control test group and is numbered as # 4. Sequentially adding a polyol protective agent, an amino acid protective agent and a saccharide protective agent into the solutions 1#, 2#, 3#, and 4#, so as to obtain hemoglobin quality control product diluents 1#, 2#, 3#, and 4#, wherein the mass fraction of the polyol protective agent in the hemoglobin quality control product diluents is 2%, the mass fraction of the amino acid protective agent in the hemoglobin quality control product diluents is 2%, and the mass fraction of the saccharide protective agent in the hemoglobin quality control product diluents is 2%. The polyalcohol protective agent is a mixture of sorbitol and polyethylene glycol, the mass ratio of the sorbitol to the polyethylene glycol is 1:1, the amino acid protective agent is glycine, and the saccharide protective agent is sucrose. 0.005mL of hemoglobin quality control sample is added into the hemoglobin quality control dilution solution No. 1, No. 2, No. 3, No. 4 to form a hemoglobin quality control solution No. 1, No. 2, No. 3, No. 4.

Freeze-drying the obtained hemoglobin quality control solution No. 1, No. 2, No. 3 and No. 4 according to a preset freeze-drying program, wherein the preset freeze-drying program is as follows: pre-freezing at-40 deg.C for 5 hr, freezing at-40 deg.C, vacuumizing for 3 hr, freezing at-20 deg.C, vacuumizing for 2 hr, freezing at 0 deg.C, and vacuumizing for 2 hr; and respectively detecting the difference of the quality control products before and after freeze-drying, and calculating the residual rate.

The concentration of the hemoglobin control was measured by a dry immunofluorescence analyzer using an immunological hemoglobin measurement reagent and a fecal hemoglobin detection kit, and the measurement results are shown in table 1.

TABLE 1

Buffering agent	Before freeze-drying (mu g/g) of hemoglobin quality control product	Lyophilized hemoglobin quality control product (mu g/g)	Survival Rate (%)
				Potassium borate	63.56	7.5	18.8
Potassium phosphate	123.73	109.81	88.75
				Tris (hydroxymethyl) aminomethane	112.90	87.35	77.37
Purified water	85.27	8.9	10.44

As shown in Table 1, compared with the control test group, the hemoglobin quality control solution added with 100mM potassium borate, potassium phosphate and tris (hydroxymethyl) aminomethane with pH7.4 as the buffer of the hemoglobin quality control has remarkable protection effect on the freeze-dried hemoglobin quality control; wherein, after the hemoglobin control product is freeze-dried, the residual rate of potassium borate is 18.8 percent, the residual rate of potassium phosphate is 88.75 percent, and the residual rate of tris (hydroxymethyl) aminomethane is 77.37 percent. It is understood that the phosphate buffer has a significant effect of protecting the hemoglobin-controlled product under the conditions of example 1, and potassium phosphate is the most preferable buffer.

Example 2

Taking 10mL of 100mM pH7.4 potassium phosphate five parts, wherein the potassium phosphate solution five parts are numbered as 1#, 2#, 3#, 4#, and 5 #.

Respectively adding a polyol protective agent, an amino acid protective agent and a saccharide protective agent into the No. 1, No. 2, No. 3 and No. 4 solutions in sequence to obtain a hemoglobin quality control product diluent No. 1, No. 2, No. 3 and No. 4, wherein the mass fraction of the polyol protective agent in the hemoglobin quality control product diluent is 2%, the mass fraction of the amino acid protective agent in the hemoglobin quality control product diluent is 2%, and the mass fraction of the saccharide protective agent in the hemoglobin quality control product diluent is 2%. Wherein glycerol is added into the 1# potassium phosphate solution; adding xylitol into the No. 2 potassium phosphate solution; adding mannitol into 3# potassium phosphate solution; adding a mixture of sorbitol and polyethylene glycol into the 4# potassium phosphate solution, wherein the mass ratio of the sorbitol to the polyethylene glycol is 1: 1; and sequentially adding purified water, an amino acid protective agent and a carbohydrate protective agent into the 5# potassium phosphate solution to serve as a control group to obtain a hemoglobin quality control product diluent No. 5, wherein the mass fraction of the purified water in the hemoglobin quality control product diluent No. 5 is 2%, the mass fraction of the amino acid protective agent in the hemoglobin quality control product diluent No. 2% and the mass fraction of the carbohydrate protective agent in the hemoglobin quality control product diluent No. 2%.

In the hemoglobin quality control product diluent No. 1, No. 2, No. 3, No. 4 and No. 5, the amino acid protective agent is glycine, and the saccharide protective agent is sucrose. 0.005mL of the hemoglobin quality control product sample is added into the 1#, 2#, 3#, 4#, and 5# hemoglobin quality control product diluent respectively to form a hemoglobin quality control product solution 1#, 2#, 3#, 4#, and 5 #.

Freeze-drying the obtained hemoglobin control solution 1#, 2#, 3#, 4#, 5# according to a set freeze-drying program, wherein the preset freeze-drying program is as follows: pre-freezing for 5 hours, freezing and vacuumizing for 3 hours at minus 40 ℃, freezing and vacuumizing for 3 hours at minus 20 ℃, freezing and vacuumizing for 2 hours at 0 ℃, and freezing and vacuumizing for 2 hours at 10 ℃; and respectively detecting the difference of the quality control products before and after freeze-drying, and calculating the residual rate.

TABLE 2

Polyol protectant	Before freeze-drying (mu g/g) of hemoglobin quality control product	Lyophilized hemoglobin quality control product (mu g/g)	Survival Rate (%)
				Glycerol	114.90	77.62	67.55
Xylitol, its preparation method and use	112.54	92.13	81.87
				Mannitol	114.80	100.49	87.53
Sorbitol + polyethylene glycol	123.73	109.81	88.75
				Purified water	115.67	37.94	32.80

As shown in table 2, compared with the test control group, the hemoglobin control solution added with the mixture of glycerol, xylitol, mannitol, sorbitol and polyethylene glycol as the hemoglobin protective agent of the freeze-dried diluent has significant protection effect on the hemoglobin control; wherein, after the hemoglobin control product is freeze-dried, the hemoglobin residual rate of the hemoglobin control product solution of the glycerol protectant is 67.55%, the hemoglobin residual rate of the hemoglobin control product solution of the xylitol protectant is 81.87%, the hemoglobin residual rate of the hemoglobin control product solution of the mannitol protectant is 87.53%, the hemoglobin residual rate of the hemoglobin control product solution of the sorbitol and polyethylene glycol mixture protectant is 88.75%, and the hemoglobin residual rate of the hemoglobin control product solution containing the purified water protectant is 32.80%. It is known that sorbitol, a polyol-based hemoglobin protectant, has a significant protective effect on hemoglobin-based control products under the conditions of example 2, and a mixture of sorbitol and polyethylene glycol is the most preferred polyol protectant.

Example 3

Taking 10mL of 100mM potassium phosphate with pH value of 7.4, wherein the potassium phosphate solutions are numbered as No. 1, No. 2, No. 3, No. 4 and No. 5 in sequence.

And respectively adding a polyol protective agent, an amino acid protective agent and a saccharide protective agent into the No. 1, No. 2, No. 3 and No. 4 solutions in sequence to obtain a hemoglobin quality control product diluent No. 1, No. 2, No. 3 and No. 4, wherein the mass fraction of the polyol protective agent in the hemoglobin quality control product diluent is 2%, the mass fraction of the amino acid protective agent in the hemoglobin quality control product diluent is 2%, and the mass fraction of the saccharide protective agent in the hemoglobin quality control product diluent is 2%. The method comprises the following steps of adding glycine into a 1# potassium phosphate solution, adding cysteine into a 2# potassium phosphate solution, adding N-acetylcysteine into a 3# potassium phosphate solution, adding glutathione into a 4# potassium phosphate solution, and sequentially adding a polyol protective agent, purified water and a saccharide protective agent into a 5# potassium phosphate solution to serve as a control group to obtain a hemoglobin quality control product diluent 5#, wherein the polyol protective agent accounts for 2% by mass in the hemoglobin quality control product diluent, the purified water accounts for 2% by mass in the hemoglobin quality control product diluent, and the saccharide protective agent accounts for 2% by mass in the hemoglobin quality control product diluent.

The polyol protective agent in the hemoglobin quality control product diluent No. 1, No. 2, No. 3, No. 4 and No. 5 is a mixture of sorbitol and polyethylene glycol, the mass ratio of the sorbitol to the polyethylene glycol is 1:1, and the saccharide protective agent is sucrose. 0.005mL of hemoglobin quality control sample is added into the hemoglobin quality control dilution solution No. 1, No. 2, No. 3, No. 4, No. 5 to form a hemoglobin quality control solution No. 1, No. 2, No. 3, No. 4, No. 5.

TABLE 3

Amino acid protective agent	Before freeze-drying (mu g/g) of hemoglobin quality control product	Lyophilized hemoglobin quality control product (mu g/g)	Survival Rate (%)
				Glycine	123.73	109.81	88.75
Cysteine	111.58	96.44	86.43
				N-acetylcysteine	115.33	88.26	76.53
Glutathione	110.81	85.35	77.02
				Purified water	78.49	14.36	18.29

As can be seen from table 3, for the hemoglobin control solution, compared with the test control group, the protective effect of the hemoglobin control solution is significant by adding glycine, cysteine, N-acetylcysteine, and glutathione as the protective agents of the lyophilized diluent; wherein, after the hemoglobin control product is freeze-dried, the hemoglobin residual rate of the hemoglobin control product solution of the glycine protectant is 88.75%, the hemoglobin residual rate of the hemoglobin control product solution of the cysteine protectant is 86.43%, the hemoglobin residual rate of the hemoglobin control product solution of the N-acetylcysteine protectant is 76.53%, the hemoglobin residual rate of the hemoglobin control product solution of the glutathione protectant is 77.02%, and the hemoglobin residual rate of the hemoglobin control product solution of the purified water protectant is 18.29%. It is found that the amino acid hemoglobin protective agent glycine has a significant protective effect on hemoglobin control products under the conditions of example 3, and glycine is the most preferable amino acid protective agent.

Example 4

Taking 10mL of 100mM potassium phosphate with pH value of 7.4, and numbering the solutions as No. 1, No. 2, No. 3, No. 4, No. 5 and No. 6 in sequence.

And respectively adding a polyol protective agent, an amino acid protective agent and a saccharide protective agent into the 1#, 2#, 3#, 4#, and 5# solutions in sequence to obtain a hemoglobin control product diluent, wherein the mass fraction of the polyol protective agent in the hemoglobin control product diluent is 2%, the mass fraction of the amino acid protective agent in the hemoglobin control product diluent is 2%, and the mass fraction of the saccharide protective agent in the hemoglobin control product diluent is 2%. Wherein, sucrose is added into the 1# potassium phosphate solution; adding glucose into the potassium phosphate 2# solution; adding trehalose into the 3# potassium phosphate solution; adding lactose into 4# potassium phosphate solution; adding maltose into 5# potassium phosphate solution; sequentially adding a polyol protective agent, an amino acid protective agent and purified water into the 6# potassium phosphate solution to serve as a control group to obtain a hemoglobin control product diluent 6#, wherein the mass fraction of the polyol protective agent in the hemoglobin control product diluent 6# is 2%, the mass fraction of the amino acid protective agent in the hemoglobin control product diluent 6# is 2%, and the mass fraction of the purified water in the hemoglobin control product diluent 6# is 2%.

The polyhydric alcohol protective agent of each diluent is a mixture of sorbitol and polyethylene glycol, the mass ratio of the sorbitol to the polyethylene glycol is 1:1, and the amino acid protective agent is glycine. 0.005mL of hemoglobin quality control sample is added into the hemoglobin quality control dilution solution 1#, 2#, 3#, 4#, 5#, and 6# respectively to form a hemoglobin quality control solution 1#, 2#, 3#, 4#, 5#, and 6 #.

Freeze-drying the obtained hemoglobin control solution 1#, 2#, 3#, 4#, 5#, 6# according to a set freeze-drying program, wherein the preset freeze-drying program is as follows: pre-freezing for 5 hours, freezing and vacuumizing for 3 hours at minus 40 ℃, freezing and vacuumizing for 3 hours at minus 20 ℃, freezing and vacuumizing for 2 hours at 0 ℃, and freezing and vacuumizing for 2 hours at 10 ℃; and respectively detecting the difference of the quality control products before and after freeze-drying, and calculating the residual rate.

TABLE 4

As shown in table 4, the hemoglobin control solutions obtained above were significantly protected by adding sucrose, glucose, trehalose, lactose, and maltose as sugar protectors to the test control group; wherein, after the hemoglobin control product is freeze-dried, the hemoglobin residual rate of the hemoglobin control product solution of the sucrose protectant is 88.75%, the hemoglobin residual rate of the hemoglobin control product solution of the glucose protectant is 78.86%, the hemoglobin residual rate of the hemoglobin control product solution of the trehalose protectant is 75.58%, the hemoglobin residual rate of the hemoglobin control product solution of the lactose protectant is 76.60%, the hemoglobin residual rate of the hemoglobin control product solution of the maltose protectant is 79.38%, and the hemoglobin residual rate of the hemoglobin control product solution of the purified water protectant is 52.27%. It is known that the carbohydrate hemoglobin protectant sucrose has a significant protective effect on hemoglobin control products under the conditions of example 4, and sucrose is the most preferred sucrose protectant.

Example 5

Taking 10mL of 100mM potassium phosphate with pH7.4, and sequentially adding a mixture of sorbitol and polyethylene glycol, glycine and sucrose to obtain a hemoglobin control product diluent, wherein the mass fraction of the mixture of sorbitol and polyethylene glycol in the hemoglobin control product diluent is 1%, the mass fraction of glycine in the hemoglobin control product diluent is 1%, the mass fraction of sucrose in the hemoglobin control product diluent is 1%, and the mass ratio of sorbitol to polyethylene glycol is 1: 1. Adding 0.005mL of hemoglobin quality control sample into the hemoglobin quality control dilution to obtain hemoglobin quality control solution.

Freeze-drying the obtained hemoglobin control solution according to a preset freeze-drying program, wherein the preset freeze-drying program is as follows: pre-freezing for 5 hours, freezing and vacuumizing for 3 hours at minus 40 ℃, freezing and vacuumizing for 3 hours at minus 20 ℃, freezing and vacuumizing for 2 hours at 0 ℃, and freezing and vacuumizing for 2 hours at 10 ℃; and respectively detecting the difference of the quality control products before and after freeze-drying, and calculating the residual rate.

The concentration of the hemoglobin quality control was measured by a dry immunofluorescence analyzer using an immunological hemoglobin measurement reagent and a fecal hemoglobin detection kit. The measurement results are shown in Table 5.

TABLE 5

Freeze-dried diluent	Before freeze-drying (mu g/g) of hemoglobin quality control product	Lyophilized hemoglobin quality control product (mu g/g)	Survival Rate (%)
				Low concentration of protective agent	100.52	64.37	64.04

Example 6

And (2) sequentially adding 10mL of 100mM potassium phosphate with pH value of 7.4 into a mixture of sorbitol and polyethylene glycol, glycine and sucrose to obtain a hemoglobin quality control product diluent, wherein the mass fraction of the mixture of sorbitol and polyethylene glycol in the hemoglobin quality control product diluent is 10%, the mass fraction of glycine in the hemoglobin quality control product diluent is 10%, the mass fraction of sucrose in the hemoglobin quality control product diluent is 10%, and the mass ratio of sorbitol to polyethylene glycol is 1: 1. Adding 0.005mL of hemoglobin quality control sample into the hemoglobin quality control dilution to obtain hemoglobin quality control solution.

TABLE 6

Freeze-dried diluent	Before freeze-drying (mu g/g) of hemoglobin quality control product	Lyophilized hemoglobin quality control product (mu g/g)	Survival Rate (%)
				High concentration of protective agent	92.55	61.28	66.21

The above is only a preferred embodiment of the present invention, and it should be noted that the above preferred embodiment should not be considered as limiting the present invention, and the protection scope of the present invention should be subject to the scope defined by the claims. It will be apparent to those skilled in the art that various modifications and adaptations can be made without departing from the spirit and scope of the invention, and these modifications and adaptations should be considered within the scope of the invention.

9页详细技术资料下载

Preparation method of hemoglobin control freeze-dried product

相关技术

网友询问留言